Aurobindo Pharma Usa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for AUROBINDO PHARMA USA
AUROBINDO PHARMA USA has seventy approved drugs.
There are two tentative approvals on AUROBINDO PHARMA USA drugs.
Summary for Aurobindo Pharma Usa
| US Patents: | 0 |
| Tradenames: | 60 |
| Ingredients: | 59 |
| NDAs: | 70 |
| Patent Litigation for Aurobindo Pharma Usa: | See patent lawsuits for Aurobindo Pharma Usa |
| PTAB Cases with Aurobindo Pharma Usa as petitioner: | See PTAB cases with Aurobindo Pharma Usa as petitioner |
Drugs and US Patents for Aurobindo Pharma Usa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Usa | WARFARIN SODIUM | warfarin sodium | TABLET;ORAL | 040415-001 | Sep 27, 2004 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Aurobindo Pharma Usa | RABEPRAZOLE SODIUM | rabeprazole sodium | TABLET, DELAYED RELEASE;ORAL | 205761-001 | Feb 17, 2017 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Aurobindo Pharma Usa | PRAVASTATIN SODIUM | pravastatin sodium | TABLET;ORAL | 076056-001 | Apr 24, 2006 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Aurobindo Pharma Usa | SOTALOL HYDROCHLORIDE | sotalol hydrochloride | TABLET;ORAL | 077616-002 | Feb 7, 2007 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Aurobindo Pharma Usa | BUDESONIDE | budesonide | CAPSULE, DELAYED RELEASE;ORAL | 090410-001 | May 16, 2011 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Aurobindo Pharma Usa | TOLTERODINE TARTRATE | tolterodine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 201486-002 | Oct 31, 2013 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Aurobindo Pharma Usa
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Usa | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,105,783 | ⤷ Start Trial |
| Aurobindo Pharma Usa | MAXZIDE-25 | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-003 | May 13, 1988 | 4,444,769 | ⤷ Start Trial |
| Aurobindo Pharma Usa | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,444,769 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
